Clinically relevant inflammatory breast cancer patient-derived xenograft–derived ex vivo model for evaluation of tumor-specific therapies

Inflammatory breast cancer (IBC) is a rare and aggressive presentation of invasive breast cancer with a 62% to 68% 5-year survival rate. It is the most lethal form of breast cancer, and early recognition and treatment is important for patient survival. Like non-inflammatory breast cancer, IBC compri...

Descripción completa

Detalles Bibliográficos
Autores principales: Eckhardt, Bedrich L., Gagliardi, Maria, Iles, LaKesla, Evans, Kurt, Ivan, Cristina, Liu, Xiuping, Liu, Chang-Gong, Souza, Glauco, Rao, Arvind, Meric-Bernstam, Funda, Ueno, Naoto T., Bartholomeusz, Geoffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955489/
https://www.ncbi.nlm.nih.gov/pubmed/29768500
http://dx.doi.org/10.1371/journal.pone.0195932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955489/
https://www.ncbi.nlm.nih.gov/pubmed/29768500
http://dx.doi.org/10.1371/journal.pone.0195932

Ejemplares similares